We speculated that the ligands of NPC tumor cells may bind to various inhibitory receptors of NK cells, such as TIGIT, LAG3 and TIM-3, and reduce the cytotoxicity of NK cells. The gene discussed is HAVCR2; the disease is nasopharyngeal carcinoma.